Skip to main content
Follow Gene Therapy Net on X LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 

The GMO aspects of clinical trials with medicinal products for human use containing or consisting of GMOs are regulated under the deliberate release framework- Part B of Directive 2001/18. Authorization of GMO aspects is required prior to the submission of the clinical trial application.

Additional information can be found at:
- https://www.sukl.sk/en/clinical-trials/instructions?page_id=2821
- State Institute for Drug Control (SIDC)

Application forms to seek authorisation for the GMO aspects
The details of the application are set in the Decree No. 399/2005 ( https://bch.cbd.int/database/record.shtml?documentid=47486

Public consultation
The Ministry informs the public about applications for approval as well as on issued permits through the Internet (https://www.minzp.sk/postupy-ziadosti/geneticky-modifikovane-organizmy/pripomienky-k-ziadostiam-ohlaseniam/), and by any other appropriate means as well if it is necessary to effectively inform the public, with a call for public comments within a deadline of 30 days.


National authorities involved

Authorization of clinical trials:
The State Institute for Drug Control
Department of Clinical Trials, Kvetná 11, 825 08 Bratislava
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Authorisation of GMO aspects:
Ministry of Environment of the Slovak Republic
Department of Environmental Hazards and Biosafety Námestie Ľ. Štúra 1,812 35 Bratislava
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.; This email address is being protected from spambots. You need JavaScript enabled to view it.

(Last reviewed by the Competent Authority: December 2017)